Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient.

× No keyword cloud information.

4 in total

1. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.

Authors: Stuart L Goldberg; Andrew L Pecora; Robert S Alter; Mark S Kroll; Scott D Rowley; Stanley E Waintraub; Kavita Imrit; Robert A Preti
Journal: Blood Date: 2002-02-15 Impact factor: 22.113

2. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

Authors: F Suzan; M Ammor; V Ribrag
Journal: N Engl J Med Date: 2001-09-27 Impact factor: 91.245

3. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.

Authors: M S Czuczman; A J Grillo-López; C A White; M Saleh; L Gordon; A F LoBuglio; C Jonas; D Klippenstein; B Dallaire; C Varns
Journal: J Clin Oncol Date: 1999-01 Impact factor: 44.544

4. Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors: Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal: J Clin Oncol Date: 2004-07-15 Impact factor: 44.544

4 in total

3 in total

Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient.

1. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.

2. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

3. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.

4. Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Review 1. Does rituximab increase the incidence of infectious complications? A narrative review.

2. Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.

3. Gastric Outlet Obstruction due to Cytomegalovirus Infection in an Immunocompromised Patient.